073187962	073187962	CD	B-NP	O
|	|	NN	I-NP	O
C	C	NN	I-NP	O
|	|	IN	B-PP	O
08150399	08150399	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4062856	4062856	CD	B-NP	O
|	|	CC	I-NP	O
9/10/2006	9/10/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
OSTEOMYELITIS	OSTEOMYELITIS	NNP	I-NP	I-protein
LT.	LT.	NNP	I-NP	I-protein
FOOT	FOOT	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/5/2006	5/5/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/11/2006	4/11/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
MOHOROVICH	MOHOROVICH	NNP	B-NP	O
,	,	,	O	O
BARRY	BARRY	NNP	B-NP	O
MD	MD	NNP	I-NP	O
DATE	DATE	NNP	I-NP	O
OF	OF	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
4/5/06	4/5/06	CD	B-NP	O
DATE	DATE	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
:	:	:	O	O
2/29/06	2/29/06	CD	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
72-year-old	72-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
plantar	plantar	NN	I-NP	O
fifth	fifth	JJ	I-NP	O
metatarsal	metatarsal	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
since	since	IN	B-PP	O
3/14	3/14	CD	B-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
previously	previously	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
ulcer	ulcer	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
area	area	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
healed	heal	VBD	B-VP	O
successfully	successfully	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
recurrence	recurrence	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
neuropathic	neuropathic	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
worsened	worsen	VBN	I-VP	O
and	and	CC	I-VP	O
deepened	deepen	VBN	I-VP	O
with	with	IN	B-PP	O
progression	progression	NN	B-NP	O
to	to	TO	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
involving	involve	VBG	B-VP	O
the	the	DT	B-NP	O
metatarsal	metatarsal	JJ	I-NP	O
phalangeal	phalangeal	JJ	I-NP	O
joint	joint	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
wound	wound	NN	I-NP	O
healing	healing	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
confounded	confound	VBN	I-VP	O
by	by	IN	B-PP	O
longstanding	longstande	VBG	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
venous	venous	JJ	B-NP	O
stasis	stasis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ulcer	ulcer	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
previously	previously	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
debridement	debridement	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
5/23	5/23	CD	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
became	become	VBD	B-VP	O
infected	infected	JJ	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBN	B-VP	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
progressed	progress	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-NP	O
developed	develop	VBN	I-NP	O
profuse	profuse	NN	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
Clostridium	Clostridium	NNP	I-NP	O
difficile	difficile	JJ	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
Flagyl	Flagyl	NN	I-NP	O
and	and	CC	I-NP	O
vancomycin	vancomycin	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
presents	present	VBZ	B-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
continued	continue	VBN	B-NP	O
loose	loose	JJ	I-NP	O
stool	stool	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
previously	previously	RB	I-VP	O
undergone	undergo	VBN	I-VP	O
a	a	DT	B-NP	O
three-phase	three-phase	JJ	I-NP	O
bone	bone	NN	I-NP	O
scan	scan	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
and	and	CC	O	O
then	then	RB	B-VP	O
confirmed	confirm	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
gallium	gallium	NN	I-NP	O
scan	scan	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
decreased	decrease	VBN	B-NP	O
sensation	sensation	NN	I-NP	O
from	from	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
mid	mid	JJ	I-NP	O
tibia	tibia	NN	I-NP	O
extending	extend	VBG	B-VP	O
distally	distally	RB	B-ADVP	O
and	and	CC	O	O
denies	deny	VBZ	B-VP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
admitted	admit	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
facility	facility	NN	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
undergoes	undergo	VBZ	B-VP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
poor	poor	JJ	B-NP	O
ambulation	ambulation	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
wheelchair	wheelchair	WRB	B-ADVP	O
bound	bind	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
include	include	VBP	B-VP	O
her	her	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
,	,	,	O	O
venous	venous	JJ	B-NP	O
stasis	stasis	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
elevated	elevated	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
neuropathy	neuropathy	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Lower	Low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
venous	venous	JJ	B-NP	O
stasis	stasis	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Right	Right	NN	B-NP	O
knee	knee	NN	I-NP	O
gout	gout	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Ischemic	Ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
requiring	require	VBG	B-VP	O
AICD	AICD	NNP	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
removal	removal	NN	I-NP	O
of	of	IN	B-PP	O
thyroid	thyroid	JJ	B-NP	O
tumor	tumor	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
triple	triple	JJ	B-NP	O
bypass	bypass	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarctions	infarction	NNS	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
placement	placement	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
stents	stent	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Atorvastatin	Atorvastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
,	,	,	O	O
gabapentin	gabapentin	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
fentanyl	fentanyl	NN	B-NP	O
patch	patch	NN	I-NP	O
50	50	CD	B-NP	O
mcg	mcg	NN	I-NP	O
an	an	DT	B-NP	O
hour	hour	NN	I-NP	O
q.	q.	NN	I-NP	O
72	72	CD	I-NP	O
h.	h.	NN	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
80	80	CD	I-NP	O
mEq	mEq	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
omeprazole	omeprazole	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
vancomycin	vancomycin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Flagyl	Flagyl	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
25	25	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
oxycodone	oxycodone	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
h.	h.	NN	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Sulfa	Sulfa	NN	B-NP	O
causes	cause	VBZ	B-VP	O
angioedema	angioedema	NN	B-NP	O
.	.	.	O	O

OPERATIONS	OPERATIONS	NNS	B-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
5/5/2006	5/5/2006	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
debridement	debridement	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
and	and	CC	I-NP	O
amputation	amputation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
fifth	fifth	JJ	I-NP	O
metatarsal	metatarsal	JJ	I-NP	O
phalangeal	phalangeal	JJ	I-NP	O
joint	joint	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/19/2006	10/19/2006	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
closure	closure	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
wound	wound	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
TREATMENTS	TREATMENTS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
CT	CT	NN	B-NP	O
angiogram	angiogram	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Diffuse	Diffuse	NN	B-NP	O
atherosclerotic	atherosclerotic	JJ	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
focal	focal	JJ	I-NP	O
areas	area	NNS	I-NP	O
of	of	IN	B-PP	O
mild-to-moderate	mild-to-moderate	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
seen	see	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
origin	origin	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
SMA	SMA	NN	I-NP	B-protein
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
renal	renal	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
,	,	,	O	O
common	common	JJ	B-NP	O
and	and	CC	I-NP	O
superficial	superficial	JJ	I-NP	O
femoral	femoral	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
and	and	CC	O	O
popliteal	popliteal	JJ	B-NP	O
arteries	artery	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Occlusion	Occlusion	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
third	third	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
tibial	tibial	JJ	I-NP	O
artery	artery	NN	I-NP	O
with	with	IN	B-PP	O
distal	distal	JJ	B-NP	O
reformation	reformation	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
side	side	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Three-vessel	Three-vessel	NNP	B-NP	O
run	run	VB	B-VP	O
off	off	RP	B-PRT	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
leg	leg	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Vascular	Vascular	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
Service	Service	NNP	I-NP	O
on	on	IN	B-PP	O
5/5/2006	5/5/2006	CD	B-NP	O
after	after	IN	B-PP	O
undergoing	undergo	VBG	B-VP	O
her	her	PRP$	B-NP	O
amputation	amputation	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
concerning	concern	VBG	I-NP	O
intraoperative	intraoperative	JJ	I-NP	O
events	event	NNS	I-NP	O
occurred	occur	VBD	B-VP	O
;	;	:	O	O
please	please	VB	B-VP	O
see	see	VBP	B-VP	O
dictated	dictated	JJ	B-NP	O
operative	operative	JJ	I-NP	O
note	note	NN	I-NP	O
for	for	IN	B-PP	O
details	detail	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
PACU	PACU	NN	I-NP	B-DNA
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
adequate	adequate	JJ	B-NP	O
pain	pain	NN	I-NP	O
control	control	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
tolerating	tolerate	VBG	I-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
diet	diet	NN	I-NP	O
by	by	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
0	0	CD	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
in	in	IN	B-PP	O
light	light	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
wound	wound	NN	I-NP	O
was	be	VBD	B-VP	O
clean	clean	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
hematoma	hematoma	NN	B-NP	O
collection	collection	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
wet-to-dry	wet-to-dry	JJ	B-NP	O
dressing	dress	VBG	I-NP	O
changes	change	NNS	I-NP	O
t.i.d.	t.i.d.	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
CT	CT	NN	I-NP	O
angiogram	angiogram	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
her	her	PRP	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
vasculature	vasculature	NN	I-NP	O
;	;	:	O	O
please	please	VB	B-VP	O
see	see	VB	I-VP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
noted	note	VBD	B-VP	O
above	above	IN	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
section	section	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
summary	summary	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
three-vessel	three-vessel	JJ	I-NP	O
run	run	NN	I-NP	O
off	off	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
not	not	RB	I-VP	O
likely	likely	RB	I-VP	O
need	need	VB	I-VP	O
a	a	DT	B-NP	O
bypass	bypass	NN	I-NP	O
for	for	IN	B-PP	O
wound	wound	NN	B-NP	O
healing	heal	VBG	B-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
because	because	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
wound	wound	NN	I-NP	O
was	be	VBD	B-VP	O
clean	clean	JJ	B-ADJP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Fregeau	Fregeau	NNP	I-NP	O
deemed	deem	VBD	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
appropriate	appropriate	JJ	B-ADJP	O
to	to	TO	B-VP	O
proceed	proceed	VB	I-VP	O
the	the	DT	B-NP	O
closure	closure	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
10/19/2006	10/19/2006	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
closure	closure	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
wound	wound	NN	I-NP	O
;	;	:	O	O
please	please	VB	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Visage	Visage	NNP	I-NP	O
's	's	POS	B-NP	O
dictated	dictated	JJ	I-NP	O
operative	operative	JJ	I-NP	O
note	note	NN	I-NP	O
for	for	IN	B-PP	O
details	detail	NNS	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
both	both	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
procedures	procedure	NNS	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
pain	pain	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
status	status	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
postoperatively	postoperatively	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home/rehabilitation	home/rehabilitation	NN	I-NP	O
facility	facility	NN	I-NP	O
medication	medication	NN	I-NP	O
regimen	regimen	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
respiratory	respiratory	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
loose	loose	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
regimen	regimen	NN	I-NP	O
for	for	IN	B-PP	O
Clostridium	Clostridium	NN	B-NP	O
difficile	difficile	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
Flagyl	Flagyl	NN	I-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
attempts	attempt	NNS	I-NP	O
to	to	TO	B-VP	O
save	save	VB	I-VP	O
a	a	DT	B-NP	O
stool	stool	NN	I-NP	O
specimen	specimen	NN	I-NP	O
;	;	:	O	O
either	either	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
save	save	VB	I-VP	O
the	the	DT	B-NP	O
stool	stool	NN	I-NP	O
at	at	IN	B-PP	O
times	time	NNS	B-NP	O
or	or	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
mixed	mix	VBN	B-ADJP	O
with	with	IN	B-PP	O
copious	copious	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
urine	urine	NN	B-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
Clostridium	Clostridium	NN	I-NP	O
difficile	difficile	JJ	I-NP	O
test	test	NN	I-NP	O
is	be	VBZ	B-VP	O
pending	pende	VBG	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
for	for	IN	B-PP	O
test	test	NN	B-NP	O
of	of	IN	B-PP	O
cure	cure	NN	B-NP	O
while	while	IN	B-SBAR	O
at	at	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hemodynamic	hemodynamic	JJ	I-NP	O
status	status	NN	I-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
closely	closely	RB	B-ADVP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
her	her	PRP$	B-NP	O
fluid	fluid	NN	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
1500	1500	CD	I-NP	O
mL	mL	NN	I-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
CHF	CHF	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
rise	rise	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
from	from	IN	B-PP	O
1.4	1.4	CD	B-NP	O
to	to	TO	B-PP	O
1.8	1.8	CD	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
trending	trend	VBG	I-VP	O
back	back	RB	B-ADVP	O
down	down	RB	I-ADVP	O
to	to	TO	B-PP	O
1.4	1.4	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
were	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
and	and	CC	O	O
repeated	repeat	VBN	B-VP	O
as	as	RB	B-ADJP	O
necessary	necessary	JJ	I-ADJP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
subcutaneous	subcutaneous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
while	while	IN	B-SBAR	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
inpatient	inpatient	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cultures	culture	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
MRSA	MRSA	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
continued	continue	VBD	B-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
her	her	PRP	B-NP	O
IV	IV	CD	I-NP	O
vancomycin	vancomycin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
through	through	IN	B-PP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Gittins	Gittins	NNP	I-NP	O
in	in	IN	B-PP	O
clinic	clinic	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Diabetes	Diabetes	NNP	I-NP	O
Management	Management	NNP	I-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Diabetes	Diabetes	NNP	I-NP	O
Management	Management	NNP	I-NP	O
Service	Service	NNP	I-NP	O
recommended	recommend	VBD	B-VP	O
a	a	DT	B-NP	O
regimen	regimen	NN	I-NP	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
standing	standing	JJ	I-NP	O
NovoLog	NovoLog	NNP	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
a	a	DT	B-NP	O
NovoLog	NovoLog	NNP	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
relatively	relatively	RB	B-ADJP	O
unremarkable	unremarkable	JJ	I-ADJP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
with	with	IN	B-PP	O
adequate	adequate	JJ	B-NP	O
pain	pain	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
explicit	explicit	JJ	B-NP	O
instructions	instruction	NNS	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
clinic	clinic	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Kegerries	Kegerries	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	B-protein
650	650	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
h.	h.	NN	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Allopurinol	Allopurinol	DT	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Atorvastatin	Atorvastatin	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Fentanyl	Fentanyl	NN	B-NP	O
patch	patch	NN	I-NP	O
50	50	CD	B-NP	O
mcg	mcg	NN	I-NP	O
an	an	DT	B-NP	O
hour	hour	NN	I-NP	B-protein
q.	q.	NN	I-NP	I-protein
72	72	CD	I-NP	I-protein
h.	h.	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

Gabapentin	Gabapentin	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

NovoLog	NovoLog	NN	B-NP	O
sliding	slide	VBG	B-VP	O
a.c.	a.c.	NN	B-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

NovoLog	NovoLog	NN	B-NP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
a.c.	a.c.	RB	B-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
25	25	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
every	every	DT	B-NP	O
morning	morning	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
8	8	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Potassium	Potassium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
immediate	immediate	JJ	I-NP	O
release	release	NN	I-NP	O
40	40	CD	I-NP	O
mEq	mEq	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Flagyl	Flagyl	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Omeprazole	Omeprazole	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Oxycodone	Oxycodone	NN	B-NP	B-protein
5-10	5-10	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
h.	h.	NN	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Torsemide	Torsemide	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
18	18	CD	I-NP	O
.	.	.	O	O

Triamcinolone	Triamcinolone	NN	B-NP	O
0.1	0.1	CD	I-NP	O
%	%	NN	I-NP	O
topical	topical	JJ	I-NP	O
daily	daily	JJ	I-NP	O
applied	apply	VBN	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
shin	shin	NN	I-NP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Vancomycin	Vancomycin	NN	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
24	24	CD	B-NP	O
h.	h.	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
this	this	DT	B-NP	O
medication	medication	NN	I-NP	O
through	through	IN	B-PP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Foesch	Foesch	NNP	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
length	length	NN	I-NP	O
of	of	IN	B-PP	O
treatment	treatment	NN	B-NP	O
.	.	.	O	O

20	20	CD	B-NP	O
.	.	.	O	O

Vancomycin	Vancomycin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
PENDING	PENDING	NN	I-NP	O
RESULTS	RESULTS	NNS	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
dictation	dictation	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
stool	stool	NN	I-NP	O
specimen	specimen	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
way	way	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
microbiology	microbiology	NN	I-NP	B-protein
lab	lab	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
for	for	IN	B-PP	O
test	test	NN	B-NP	O
of	of	IN	B-PP	O
cure	cure	NN	B-NP	O
.	.	.	O	O

PHYSICIAN	PHYSICIAN	NN	B-NP	O
FOLLOW-UP	FOLLOW-UP	NN	I-NP	O
PLANS	PLANS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Nelms	Nelms	NNP	I-NP	O
in	in	IN	B-PP	O
approximately	approximately	RB	B-NP	O
one	one	CD	I-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
wound	wound	NN	I-NP	O
and	and	CC	I-NP	O
length	length	NN	I-NP	O
of	of	IN	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
6-5913167	6-5913167	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
WOELFL	WOELFL	NNP	B-NP	O
,	,	,	O	O
BURL	BURL	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GERKIN	GERKIN	NN	B-NP	O
,	,	,	O	O
CLAIR	CLAIR	NN	B-NP	O
Dictation	Dictation	NN	I-NP	O
ID	ID	NN	I-NP	O
9259389	9259389	CD	I-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
2/29/06	2/29/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/29/06	2/29/06	CD	B-NP	O

